Microsoft Appoints Mustafa Suleyman to Lead Consumer AI Unit

Microsoft Appoints Mustafa Suleyman to Lead Consumer AI Unit

In a significant move, Microsoft has appointed Mustafa Suleyman, co-founder of DeepMind, to head its consumer AI unit. As part of this transition, most of the staff from Suleyman’s startup, Inflection AI, has also joined Microsoft. This step marks the first time that all of Microsoft’s consumer artificial intelligence business will be supervised by a single leader.… Read the rest

Alphabet and Apple in Talks for Artificial Intelligence Integration

Alphabet and Apple in Talks for Artificial Intelligence Integration

In a groundbreaking development, technology giants Alphabet and Apple are rumored to be discussing the integration of Alphabet’s revolutionary artificial intelligence model, Gemini, into Apple devices. While neither company has officially confirmed the talks, the potential collaboration signals a significant step forward in the ongoing competition between Alphabet and Microsoft in the artificial intelligence chatbot market.… Read the rest

Mustafa Suleyman to Lead Microsoft AI Division, Cementing the Company’s Leadership in Artificial Intelligence

Mustafa Suleyman to Lead Microsoft AI Division, Cementing the Company’s Leadership in Artificial Intelligence

Microsoft has officially announced that Mustafa Suleyman, a prominent British artificial intelligence (AI) researcher and entrepreneur, will be leading its newly-formed division, Microsoft AI. Suleyman, widely recognized for co-founding the highly esteemed AI firm DeepMind, currently heads start-up Inflection AI. This move by Microsoft solidifies its position as a frontrunner in the field of AI, where Google has been facing challenges.… Read the rest

Novo Nordisk Invests in AI-Powered Supercomputer for Drug Discovery

Novo Nordisk Invests in AI-Powered Supercomputer for Drug Discovery

Novo Nordisk, the pharmaceutical company behind the innovative drugs Ozempic and Wegovy, is investing in a cutting-edge supercomputer powered by Nvidia’s artificial intelligence technology. The Novo Nordisk Foundation has chosen Eviden, a computing company based in France, to build this powerful supercomputer that aims to revolutionize the field of drug discovery and treatment.… Read the rest

Privacy policy
Contact